ArticleArchives of microbiology2026
Anti-Aspergillus flavus activity and probiotic properties of lactic acid bacteria isolated from the digestive tract of edible crickets.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fungus Aspergillus flavus is one of the most important mycotoxigenic species that produces potent carcinogenic secondary metabolites called aflatoxins, and its harmful ability has a considerable negative impact on human and livestock health. This study assessed an antifungal activity against A. flavus and evaluated in vitro probiotic properties of lactic acid bacteria newly isolated from the digestive tract of two popular edible crickets, Gryllus bimaculatus (GL) and Acheta domesticus (AL). Moreover, metabolic profiles including anti-A. flavus compounds produced by promising lactic acid bacteria were investigated. In total of 22 isolates, four lactic acid bacterial candidates comprising AL01, GL01, GL05, and GL11 exhibited inhibitory effect on mycelial growth and anti-fungal spore germination of Aspergillus flavus TISTR 3366. Based on molecular analysis of 16S rRNA gene sequences and biochemical tests using API 50 CHL, these isolates were identified as Lacticaseibacillus paracasei (AL01), Lacticaseibacillus rhamnosus (GL01, and GL11), and Pediococcus pentosaceus (GL05). Among them, two potential strains comprising Lb. paracasei AL01 and P. pentosaceus GL05 showed the potent probiotic characteristics based on bacterial viability in gastrointestinal tract conditions, good cell surface properties, and bacterial safety. Metabolic profiles of the cell-free supernatant (CFS) obtained from AL01- and GL05-cultures were investigated using gas chromatography mass spectrometry (GC-MS), and revealed a complex mixture of bioactive compounds, including short-chain hydrocarbons, organic acids, and other antifungal metabolites. Overall results suggested that the lactic acid bacteria obtained from edible crickets can be a promising probiotic and biocontrol agent against A. flavus. The finding in this study benefits for biologically reducing mycotoxicity of harmful fungi in food and agriculture.
Indexed as
Identifiers
41848803What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.